KalVista Pharmaceuticals
KALV
#6279
Rank
C$0.89 B
Marketcap
$18.00
Share price
0.85%
Change (1 day)
25.61%
Change (1 year)

EPS for KalVista Pharmaceuticals (KALV)

EPS in 2023 (TTM): -$4.26

According to KalVista Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$4.38. In 2022 the company made an earnings per share (EPS) of -$5.18 a decrease over its 2021 EPS that were of -$3.70.

EPS history for KalVista Pharmaceuticals from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.26-17.78%
2022-$5.1840.07%
2021-$3.7028.37%
2020-$2.8841.5%
2019-$2.0418.55%
2018-$1.72-49.8%
2017-$3.42
2015-$20.95-6.99%
2014-$22.52

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.02-31.01%๐Ÿ‡บ๐Ÿ‡ธ USA